MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2023 Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a foreword from MedAxiom President and CEO Jerry Blackwell, MD, MBA, FACC, on the consistency of year-over-year data from 2021 to 2022, the importance of a robust pool of data to form the foundation of the report, and the application of data as a strategic planning tool.
2023 Report Highlights:
"The story of the 2023 MedAxiom Cardiovascular Provider Compensation and Production Survey Report is one of consistency between the 2022 and 2021 trends after several unprecedented years of change in the cardiology industry," said Blackwell. "While the healthcare field continues to evolve, the consistency of year-over-year data may reflect a turning tide, bringing renewed hope for stability and growth in the future."
The 2023 report includes 2022 data collected from 198 cardiovascular programs representing 5,806 total cardiovascular providers.
"This report is an incredibly valuable tool for leaders who can use the data to develop plans and budget sensibly for recognized market trends, provider recruitment and retention strategies," noted Kevin Mair, MBA, MedAxiom's vice president of Care Transformation Services.
The full report is available here.
About MedAxiom
MedAxiom, an American College of Cardiology Company, is the cardiovascular community's premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of hundreds of cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and dozens of industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. For additional information, visit MedAxiom.com.